Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03817905 · ClinicalTrials.gov registry record · NA
Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03817905: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT03817905 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03817905, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study seeks to determine whether a patient navigator can help improve follow up care after a stool test shows the presence of blood or other abnormal markers.
Primary Outcome
Feasibility of a navigator based intervention to improve follow up will be determined by comparing the colonoscopy completion rate to historical controls. This will be measured as number of participants completing a follow-up colonoscopy procedure.
Interventions
- OTHER Patient navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03817905 record still lists
NCT03817905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient navigator is the first listed.
NCT03817905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03817905 about?
NCT03817905 is a clinical study titled "Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach". This study seeks to determine whether a patient navigator can help improve follow up care after a stool test shows the presence of blood or other abnormal markers.
What is the current status of trial NCT03817905?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-09-01. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03817905?
The interventions under investigation include: Patient navigator (OTHER).
Who is sponsoring clinical trial NCT03817905?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03817905's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI